See the Risk Before It Becomes Cost
Most quality systems look compliant.
Few are designed to perform under pressure.
Right Brain Left Brain Consulting provides structured QA/RA risk assessments that surface hidden gaps, operational bottlenecks, and regulatory exposure—before they impact your business or investment.
⚙️ WHAT THIS IS
A practical, evidence-based view of how your quality system actually performs
This is not a checklist audit.
It is a structured assessment of your QA/RA system across critical areas, including:
quality system execution
CAPA effectiveness
complaint handling and traceability
inspection and validation controls
regulatory readiness
Each area is evaluated based on real evidence and translated into a clear risk profile.
🧭 WHAT YOU GET
A clear, executive-level view of risk—without needing to interpret raw audit data.
Each assessment includes:
a structured review across key QA/RA categories
risk ratings (Low, Moderate, High)
clear rationale tied to observed evidence
targeted recommendations
a prioritization roadmap aligned to effort and ROI
The output is designed for decision-making, not just documentation.
🔍 WHY IT MATTERS
It shows Quality system risk does not stay contained.
It shows up as:
delayed audits
regulatory findings
production inefficiencies
increased cost of quality
missed growth opportunities
Identifying these risks early allows you to act before they impact operations or valuation.
🌍 WHO THIS IS FOR
Private equity firms evaluating regulated businesses
Executive teams preparing for growth, acquisition, or audit
Quality leaders who need an objective view of system performance
Organizations adopting AI and needing to understand new compliance risks
🔷 PROVEN EXPERIENCE
Extensive experience transforming quality systems in Fortune 500 and mid-market medical device organizations, with a focus on restoring performance, eliminating systemic risk, and enabling scalable growth.
Successfully designed and led large-scale FDA remediation programs under active regulatory pressure, including enterprise-wide initiatives spanning quality systems, risk management, DHR, post-market processes, packaging and sealing validation, sterilization, materials, environmental systems, and supporting IT infrastructure.
Proven track record in restructuring QA/RA functions to eliminate backlog, improve flow, and align quality systems with operational performance and business objectives.
Led enterprise-level CAPA, nonconformance, and quality system redesign efforts, resulting in measurable improvements in throughput, cost of quality, and audit readiness.
Delivered QA/RA risk assessments and due diligence for private equity and executive teams, providing clear visibility into operational risk, compliance exposure, and post-close priorities.
Recognized for combining regulatory expertise with practical execution, translating complex quality systems into actionable insights that support both compliance and business performance.
Experience includes leading complex remediation efforts across multiple systems and functions under strict regulatory timelines, with successful outcomes accepted by regulatory authorities.
🔷 DELIVERY OPTIONS
Remote Risk Assessment
Full QA/RA Risk Assessment
A deeper evaluation across all major quality system elements.
Includes detailed risk breakdown, supporting evidence, and a full prioritization roadmap.
Due Diligence Support
Designed for investors and acquisition teams.
Focuses on identifying hidden risk, validating system performance, and supporting informed decision-making.
🔷 QA/RA IN THE AI ERA
AI introduces risk that is often invisible early.
These assessments help organizations understand:
where AI may impact regulated processes
how to maintain traceability and control
what validation approach is appropriate
This allows safe adoption without compromising compliance.
🔷 CTA
Not sure where your real risk is?
Start with a structured assessment and get a clear, actionable view of your QA/RA system.